Why the study?
Does intravenous glycopyrrolate prevent bradycardia during laryngeal spraying in children compared to routine intramuscular anticholinergics?
Does intravenous glycopyrrolate prevent bradycardia during laryngeal spraying in children compared to routine intramuscular anticholinergics?
Intravenous glycopyrrolate is more effective than intramuscular anticholinergics for preventing bradycardia during laryngeal spraying in children, though avoiding spraying altogether is recommended.
Answers are grounded in this paper and cite their sources.
May favor IV over IM anticholinergics in children; leaves open confirmation by randomized trials before practice change.
Significant and clinically important bradycardia has been observed on spraying the larynx in children irrespective of routine intramuscular administration of anticholinergic drugs. Intravenously administered anticholinergics, particularly glycopyrrolate (7.5 μg kg‐1), are more effective. It is, however, suggested that spraying the larynx may be avoided altogether in children.
No takes yet. Share an insight, caveat, or question.
R. K. Mirakhur (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: